Gupta, V. K., Pannu, D., Singh, M. P., & Kumar, L. (2023). Effect of SGLT-2 inhibitor (remogliflozin) plus DPP4 inhibitor (vildagliptin) on diabetic nephropathy in patients with type 2 diabetes mellitus comparison with combination of metformin and sulphonylureas. International Journal of Advances in Medicine, 10(6), 446–451. https://doi.org/10.18203/2349-3933.ijam20231450